These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 30723672)
41. Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures. de Biase S; Gigli GL; Nilo A; Romano G; Valente M Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):93-102. PubMed ID: 30577702 [TBL] [Abstract][Full Text] [Related]
43. Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures. Ko D; Ramsay RE Acta Neurol Scand Suppl; 2013; (197):36-43. PubMed ID: 23480155 [TBL] [Abstract][Full Text] [Related]
44. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection. Shorvon SD; Bermejo PE; Gibbs AA; Huberfeld G; Kälviäinen R Epilepsy Behav; 2018 May; 82():91-103. PubMed ID: 29602083 [TBL] [Abstract][Full Text] [Related]
45. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus. Strzelczyk A; Willems LM; Willig S; Rosenow F; Bauer S Expert Rev Clin Pharmacol; 2015; 8(6):733-40. PubMed ID: 26436331 [TBL] [Abstract][Full Text] [Related]